Auranofin in rheumatoid arthritis: use in patients with side-effects or lack of effect to gold sodium thiomalate or gold thioglucose and/or D-penicillamine. A prospective one year investigation.
Manthorpe
R
R
Department of Rheumatology TTA State University Hospital, Copenhagen, Denmark.
Tvede
N
N
Bendixen
G
G
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001310:Auranofin / Q000009:adverse effects / Q000627:therapeutic use*; D006051:Aurothioglucose / Q000009:adverse effects; D004351:Drug Resistance; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006052:Gold Sodium Thiomalate / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010396:Penicillamine / Q000009:adverse effects
D006052:Gold Sodium Thiomalate; D006051:Aurothioglucose; D001310:Auranofin; D010396:Penicillamine